Page last updated: 2024-08-26
pyrimidin-2-one beta-ribofuranoside and Leukemia P388
pyrimidin-2-one beta-ribofuranoside has been researched along with Leukemia P388 in 1 studies
*Leukemia P388: An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene. [MeSH]
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Barchi, JJ; Driscoll, JS; Kelley, JA; Liu, PS; Marquez, VE; Plowman, J | 1 |
Other Studies
1 other study(ies) available for pyrimidin-2-one beta-ribofuranoside and Leukemia P388
| Article | Year |
|---|---|
Antitumor properties of 2(1H)-pyrimidinone riboside (zebularine) and its fluorinated analogues.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Arabinonucleosides; Cytidine; Drug Screening Assays, Antitumor; Injections, Intraperitoneal; Injections, Subcutaneous; Leukemia L1210; Leukemia P388; Mice; Pyrimidine Nucleosides; Pyrimidinones; Structure-Activity Relationship | 1991 |